Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Diabetologia|March 14, 1998
Intramuscular triglyceride content is increased in IDDMP Ebeling, B Essén-Gustavsson, J A Tuominen, et al.
Metabolism: Clinical and Experimental|March 7, 2001
Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetesP Ebeling, A M Teppo, H A Koistinen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1997
Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletionJ A Tuominen, P Ebeling, H Vuorinen-Markkola, et al.
Diabetes|April 1, 1995
Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivityP Ebeling, J A Tuominen, R Bourey, et al.
Metabolism: Clinical and Experimental|January 24, 1998
The association of acetyl-L-carnitine with glucose and lipid metabolism in human muscle in vivo: the effect of hyperinsulinemiaP Ebeling, J A Tuominen, J Arenas, et al.
Acta Physiologica Scandinavica|May 1, 1997
Leptin and thermogenesis in humansJ A Tuominen, P Ebeling, M L Heiman, et al.
Diabetes/Metabolism Research and Reviews|October 12, 2000
Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjectsH A Koistinen, E Dusserre, P Ebeling, et al.
The American Journal of Clinical Nutrition|July 1, 1988
Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes: the effect of guar gumP Ebeling, H Yki-Järvinen, A Aro, et al.
Diabetes/Metabolism Research and Reviews|December 18, 2001
Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acidH A Koistinen, A Remitz, H Gylling, et al.
Diabetes Care|August 1, 1997
Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulinP Ebeling, P A Jansson, U Smith, et al.
Pageof 17